Search Clinical Trials

589,087 trials

NCT07645937
Not Yet RecruitingNot Applicable
Effects of Low-Load Blood Flow Restriction Exercise on Rectus Femoris Muscle Morphology in Individuals With Relapsing-Remitting Multiple SclerosisDicle University
NCT07644975
Not Yet RecruitingNot Applicable
Electrolytic Surface Decontamination in the Surgical Treatment of Peri-implantitis: A Randomized Clinical TrialIstanbul University
NCT07645235
Not Yet RecruitingPhase 1
A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating WomenBiomedical Advanced Research and Development Authority
NCT07645079
Not Yet RecruitingNot Applicable
Automated Insulin Delivery Versus Daily Injections for Hospital Diabetes CareSteno Diabetes Center Copenhagen
NCT07644104
Not Yet RecruitingNot Applicable
Efficacy and Safety of the Visual Bronchial Blocker for Lung Isolation SurgeryZhejiang University
NCT07646535
Not Yet RecruitingPhase 2
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary AldosteronismShenzhen Salubris Pharmaceuticals Co., Ltd.
NCT07644533
Not Yet RecruitingNot Applicable
Electroacupuncture for Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients With Advanced CancerAffiliated Hospital of Qinghai University
NCT07645560
Not Yet RecruitingPhase 2
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic StrokeBeijing Tiantan Hospital
NCT07644754
Not Yet RecruitingNot Applicable
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory MetastasesLudwig-Maximilians - University of Munich
NCT07646054
Not Yet RecruitingNot Applicable
Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers23andMe, Inc.
NCT07646548
Not Yet RecruitingPhase 1
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsRegeneron Pharmaceuticals
NCT07645105
Completed
Body Weight Reduction and Metabolic/Biochemical Parameters in Overweight or ObesityMedical University of Silesia
NCT07644936
Not Yet Recruiting
Molecular Characterization of Autoimmune Hepatitis: A Lipidomic ApproachAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
NCT07644026
Not Yet Recruiting
HBV Reactivation Prediction Model in Allo-HSCTInstitute of Hematology & Blood Diseases Hospital, China
NCT07645248
Not Yet RecruitingPhase 3
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)GlaxoSmithKline
NCT07646158
Not Yet RecruitingPhase 4
Alignment Techniques in TKA RCTJacob M. Elkins
NCT07644897
RecruitingPhase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen University
NCT07645872
Recruiting
Clinical Data Collection of Patients Treated With High Intensity Focused Ultrasound (HIFU) by the Focal One for Their Prostate Cancer.EDAP TMS S.A.
NCT07644988
Active Not RecruitingNot Applicable
Comparing Two Muscle Relaxation Techniques for Neck PainUniversity of Faisalabad
NCT07643831
Unknown
Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2- Early or Locally Advanced/Metastatic Breast CancerGenentech, Inc.